Boneu B, Immaculato F, Sie P, Caranobe C, Chamontin B, Guittard J
Nouv Presse Med. 1982 Oct 16;11(41):3043-6.
Plasma levels of three thrombin inhibitors (antithrombin III--AT-III-, alpha 2 macroglobulin - alpha 2M -; alpha 1 antitrypsin - alpha 1 AT-) were measured, together with total plasma antithrombin activity (Howie's method), in 19 hospital patients with venous thromboembolic disease before and during heparin therapy. A decrease in AT III levels was observed during treatment and found to correlate significantly with heparin plasma levels, but there were no significant changes in alpha 2M and alpha 1 AT levels. Variations in total plasma antithrombin activity were not significant. In 9 patients whose AT III levels were under 60% a significant increase in alpha 2M level was noted. The therapeutic problems associated with this category of patients are discussed.
在19例静脉血栓栓塞性疾病患者肝素治疗前及治疗期间,测定了三种凝血酶抑制剂(抗凝血酶III--AT-III-、α2巨球蛋白-α2M-;α1抗胰蛋白酶-α1AT-)的血浆水平,以及血浆总抗凝血酶活性(豪伊法)。治疗期间观察到AT III水平下降,且发现其与肝素血浆水平显著相关,但α2M和α1AT水平无显著变化。血浆总抗凝血酶活性的变化不显著。在9例AT III水平低于60%的患者中,观察到α2M水平显著升高。讨论了与此类患者相关的治疗问题。